Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 79

Pain - Basic Science

Implications for Analgesia & Analgesics

Definition of pain

Pain is an unpleasant sensory and

emotional experience associated with


actual or potential tissue damage

Sciops-Medical Division

www.iasp.org/terms

Is there a basis for the separation of pain?

A- Chronicity

B- intensity

C- Mechanism of action

Sciops-Medical Division

A- Chronicity

Acute
Sudden onset Self-limiting Generally responds to drug treatment or management of the underlying cause

Chronic
Onset not well defined Persistent or recurring Triggered by injury or disease but persists even with treatment

Acute at top of chronic (Flare up)


Sudden onset
Self-limiting Generally responds to drug treatment or management of the underlying cause

Sciops-Medical Division

B- Pain Intensity

Mild

Moderate

Sever

Sciops-Medical Division

Assessing the efficacy of analgesics


Outcome measures used in clinical studies

Assessment of pain in clinical studies


Due to its subjective nature, the assessment of pain in clinical studies is
challenging.

There are several standardized pain assessment instruments:


Pain intensity Visual Analogue Scale (VAS) Pain intensity categorical scale

Sciops-Medical Division

Pain intensity Visual Analogue Scale (VAS)


Worst pain Experienced

No pain

10

VAS score

Continuous numerical self-rating pain scale Patients mark along the line to represent pain intensity

Sciops-Medical Division

Joyce C, et al. 1975

Pain intensity categorical scale

0 = None 1 = Mild 2 = Moderate 3 = Severe

Pain categorized by number or descriptor


Patients select category to represent pain intensity
Sciops-Medical Division

Feminine pain
Physiological Psychological Perception

The Complexity of Feminine Pain


Researches over the past twenty years have found significant differences between men & women regarding the following aspects

- Physiological response to pain

- Psychological perception of pain 2

1.Zubieta et al. 2002; Gear et al. 1996 2.Campbell, Clauw, & Keefe, 2003 3.Pain." The Merck Manual of Diagnosis and Therapy,

Sciops-Medical Division

Why Females are more sensitive?


Nerve receptors
Women have averaged double the number of nerve receptors compared with men.

Hormones Variations in women's Estrogen levels like those that occur throughout the monthly menstrual cycle, or during pregnancy regulate the brain's natural ability to suppress brain. Endorphins ,Enkphalins ).
Testosterone, appears to raise the pain threshold

Sciops-Medical Division

Sciops-Medical Division

Types of acute and chronic pain


Acute
Headache/migraine Postoperative pain Dysmenorrhoea Pain following dental surgery Gout

Chronic
Osteoarthritis (OA) Rheumatoid arthritis (RA) Ankylosing spondylitis (AS) Lower back pain Cancer pain

Sciops-Medical Division

Sciencephoto.com

Incidence of acute pain in the US


US adults (%) 35 30 25 20 15 10 5 0 Migraine/ severe headache Neck pain Lower back pain Pain in face or jaw

Sciops-Medical Division

CDC. 2004

Prevalence and economic impact of chronic (persistent) pain


Worldwide, 22% of primary care patients suffer from persistent pain
every year

75 million US adults experience chronic pain 12.7% of the US work force lose productive time over a 2-week
period due to common pain conditions (arthritis, back pain, headache and other musculoskeletal conditions)

Common pain conditions cost US employers an estimated $61.2


billion in lost production time each year

Gureje O, et al. 1998; Schnitzer T. 1998; Stewart W, et al. 2003


Sciops-Medical Division

Worldwide impact of chronic pain


Primary care attendees (%) 50 40 30 20 10 0 Chronic pain No pain

Depression

Poor health

Work impaired

Activity limited

Sciops-Medical Division

Gujere O, et al. 1998

Goals of pain management


Pain control Alter disease course (may not be possible) Restore function to affected areas (e.g. joints) Address psychological factors such as stress and
depression

Maximize quality of life (QoL)

Sciops-Medical Division

Adapted from Ashburn MA. 1999

The World Health Organisation (WHO) analgesic ladder

Increasing pain

3 2
Simple analgesics
e.g. paracetamol , NSAIDs

Strong opiates
e.g. morphine or diamorphine + simple analgesics

Weak opiates
e.g. codeine or dihydrocodeine + simple analgesics

Sciops-Medical Division

Types of analgesics

Types of analgesics
Simple analgesics (paracetamol)

Nonsteroidal anti-inflammatory drugs (NSAIDs)


Weak opiates Strong opiates Corticosteroids

Sciops-Medical Division

History of NSAID to the 21st Century

History: In 1829, salicin was isolated in a pure form from the willow bark (spiraer). In 1899, introduced into medicine under the name of aspirin. Towards the end of the Nineteenth Century, other NSAID were discovered.

Sciops-Medical Division

PGs pathway

Sciops-Medical Division

PG has a big role to amplification of inflammation pain - fever .


1. Anti-inflammatory effects 2. Analgesic effects NSAIDs

suppress synthesis and release of PGs by

inhibiting Cox enzymes


which in turn block the sensitization of pain receptors.

Sciops-Medical Division

Biology & Regulation of COX-1& COXII


COX 1
Constitutive under normal conditions

COX 2
Inducible, COX-2 is typically undetectable in most tissues under basal conditions, but its expression in many cell types, including macrophages, fibroblasts, markedly depends on stimulation with inflammatory cytokines

COX-1 is expressed in virtually all tissues, most notably:


Platelets ,Endothelial cells ,GIT , kidney

COX-2 is expressed in a variety tissues in basal conditions such as:Kidney ,Brain ,Bone &Cartilage
COX-2 is rapidly induced and participates in pathological and inflammatory tissue processes.

Sciops-Medical Division

Traditional NSAIDs Mechanism of action


Platelet
Phospholipids
AA
COX-1 COX-1

GI mucosa
Phospholipids
AA
COX-1 COX-1

Inflamed synovium
Phospholipids membrane
AA
COX-1 COX-2 COX-2 COX-2

PGH2
Thromboxane synthase

PGH2
Prostacyclin synthase
Prostaglandin isomerase

PGH2
Prostacyclin synthase
Prostaglandin isomerase

TxA2

PGE2

PGI2

PGE2

PGI2

Reduction in Platelet aggregation Sciops-Medical Division platelet aggregation

Reduced Cytoprotection cytoprotection

Reduced Pain and inflammation pain and inflammation

Risk factors for GI ulcer complications


Increasing age

Aspirin use

Warfarin use

More than one NSAID

Risk of ulcer complication

Higher doses

Cardiovascular disease Corticosteroid use


Sciops-Medical Division

Previous ulcer or bleed

Wolfe M, et al. 1999

Strategies to prevent NSAID-associated GI adverse events

Administration of concomitant gastroprotectants such as PPIs (e.g.


omeprazole; Losec) prostaglandin analogues (misoprostol) are partially effective but add their own potential side effects1

Administration of NSAIDs with food reduces gastric irritation Enteric-coated tablets release drug in the small intestine, thereby preventing
direct damage to the stomach

1NICE.
Sciops-Medical Division

2001

FDA

It has been demonstrated that upper GI ulcers, gross bleeding or perforation, caused by NSAIDs, appear to occur in approximately 1% of patients treated for 3-6 months, and in about 2-4% of patients treated for one year.

Sciops-Medical Division

Musculoskeletal diseases

Common musculoskeletal diseases


Osteoarthritis A combination of Predisposing factors &joint Biomechanics(degenerative) which triggers Biochemical (Inflammatory ) changes A chronic, progressive, inflammatory disease of the joints An inflammatory disease of the joints of the back bone A form of arthritis affecting children A metabolic disease in which uric acid crystals deposit in the joints

Rheumatoid arthritis Ankylosing spondylitis Juvenile arthritis Gout

Sciops-Medical Division

Prevalence and Economic burden of musculoskeletal disease


More than 33 million people in the US (16% of the population) have a form of arthritis
28 million aged 45 years

prevalence is projected to increase to 18.2% by 2020 due to aging population

Worldwide it is estimated that 9.6% of men and 18.0% of women aged 60 years have symptomatic OA 1.02.5% of Gross National Product (GNP) is spent annually on musculoskeletal disorders in the US, Canada, UK, France and Australia

Sciops-Medical Division

March L, et al. 1997; Woolf A, et al. 2003

Disability burden of musculoskeletal diseases


Ischaemic heart disease
Cerebrovascular disease Total musculoskeletal disease OA HIV/AIDS Chronic obstructive pulmonary disease Liver cirrhosis Asthma RA 0
Sciops-Medical Division

2 4 6 8 10 Disabilityadjusted life years (millions)


Reginster J, et al. 2002

Rheumatic Disorders Classification

Gout

Tendinitis Rheumatoid Arthritis Osteoarthritis Gout Tenosynovitis Ankylosing Spondylitis Sport Injuries & strains Bursitis

Articulus: Latin word means joint


Sciops-Medical Division

Normal Joints

Normal Joint

Sciops-Medical Division

The Articular Cartilage (Hyaline cartilage)


Avascular ,Aneural
Formed of:
Water 69% Collagen 15%

Proteoglycans 15%
Chondrocytes 1%

Matrix

Function: Shock absorbent , distribute load applied on joints

Sciops-Medical Division

Structure of articular cartilage (hyaline cartilage)


1. Collagen Fibers: sheets of Fibrous proteins , Fn:provide high tensile strength to the Cartilage, resistant to extension Protect cartilage from swelling pressure generated by proteoglycans 2. Condrocytes :Mature cartilage, cellular manufacturing sites Fn: Production & Maintenance Of surrounding matrix

protein

3. Proteoglycans: Large ,high molecular weight molecules ,Available in aggregates, Consist of protein core and Carbohydrate Side chain (Chondroitin sulphate and keratin sulphate) and long central chain of hyaloronic acid, Hygroscopic i.e. attract water to make a hydrated tissue Sciops-Medical Division that resist compression

Osteoarthritis

Prevalence
Leading cause of chronic disability in elderly

The most common joint disease.


35% of rheumatic consultations

30% of women aged between 45-64 years suffer from O.A


And 70% for patients with age above than 65 years

Sciops-Medical Division

A Multifactorial Disease
O.A is a Combination of predisposing factors & joint biomechanics leading to biochemical Changes.
1 2 3

Adapted from The Lancet, Vol 365, Dieppe PA, Lohmander S. Pathogenesis and management of pain in osteoarthritis, Pages 965-973, Copyright 2005, with permission from Elsevier

Pathogenesis of OA ( Predisposing Factors)


Susceptibility to OA may be increased in part by:
genetic inheritance (a positive family history increases risk), age, ethnicity, diet and

female gender

Felson DT (2004a) An update on the pathogenesis and epidemiology of osteoarthritis. Radiologic Clin North Am 42, 19.

Pathogenesis of OA ( Joint Biomechanics)


(Mechanical leads to structural changes)

Loading can also be affected by


Obesity & Joint injury (either acutely as in a sporting injury or after repetitive overuse such as occupational exposure), both of which can increase the likelihood of development or progression of OA)

Local mechanical factors that facilitate progression


Malalignment
Muscle weakness Structural integrity (menisical damage of bone marrow lesions)

Felson DT (2004a) An update on the pathogenesis and epidemiology of osteoarthritis. Radiologic Clin North Am 42, 19.

Pathogenesis of OA (Biochemical Changes)


OA results from an imbalance in catabolic and anabolic
processes that lead to progressive cartilage damage and destruction.

Initially anabolic process such as proteoglycan synthesis


maintain balance with catabolic processes and damage to cartilage is repaired. However with time and age ,anabolic processes decline and progressive damage ensues.

Osteoarthritis and Cartilage (2008) 16, 624e630

Pathogenesis of OA (biochemical)
Often the slow but efficient OA process compensates for
the insults, resulting in an anatomically altered but symptom free functioning joint (compensated OA)

Sometimes because of severe increased insult or poor


repair response, it fails resulting in progressive tissue damage and presentation of symptoms due to joint failure.

Osteoarthritis and Cartilage (2008) 16, 624e630

4 3 3 2

Sciops-Medical Division

Sciops-Medical Division

Joint involvement in OA

Solomon L. Clinical features of osteoarthritis. Textbook Rheum 1997;2:13831393.

Clinical Manifestations
Pain and Stiffness

Tenderness and swelling


Crepitus ; irregular joint Functional impairment

Crepitus :Crackling or popping sounds created when two rough surfaces in the human body come into contact
Sciops-Medical Division

Knee Osteoarthritis
In the early stages of the disease, pain

is the

main symptom, yet in advanced stages,


cartilage degeneration takes place and the

patient also complains from a sound.

Main symptoms:

Localized knee

Pain during movement movement related pain

Resting stiffness excessive use of


54

In severe cases, pain is continuous even during rest. Mechanical pain might also increase with the joint, and this appears at night.

Deformities

Knee joint effusion

Osteoarthritis and Cartilage (2008) 16, 624e630

Heberdens nodes :Hard or bony swellings which can develop in the distal interphalangeal joints (DIP). Bouchard's nodes: bony growths in the proximal interphalangeal (PIP) joints
Sciops-Medical Division

Special Investigations
Blood tests: Normal

Radiological features:
Cartilage loss Narrowed joint space Subchondral sclerosis Cysts Osteophytes

Sciops-Medical Division

Radiographic Features of the Knee in OA


Joint space narrowing Marginal osteophytes Subchondral cysts Boney sclerosis Malalignment
Joint space narrowing

Osteoarthritis and Cartilage (2008) 16, 624e630

Goals of The Treatment


Relief pain, swelling and inflammation.
Inhibit joint degeneration. Improve quality of life.

Osteoarthritis and Cartilage (2008) 16, 624e630

Components of Multimodal Osteoarthritis Treatment

Surgery

Intra-articular Injection Hyaluronic acids Corticosteroids Pharmacological Therapy


NSAIDs Topical DMAs

Non-pharmacological Therapy
Education Physical therapy Occupational therapy Weight Control devices Nutraceuticals Exercise Assistive

Osteoarthritis and Cartilage (2008) 16, 624e630

Rheumatoid arthritis

What is Rheumatoid Arthritis ( RA )


Systemic multi-organ inflammatory disease Of unknown aetiology. NORMAL RA

Sciops-Medical Division

What is rheumatoid arthritis ?


It is a systemic multi organ inflammatory disease of unknown etiology. Associated with characteristics of joint pathology. Auto antibodies Immunologic hyperactivity The cause is unknown ,however the following factors contribute to the etiology: Heredity Infections Rheumatic factor: IgM detected in 85% of R.A patients (seropostive) ,associated with more severe joint disease and subcutaneous nodes Over activity of immune system over individuals own cells

Sciops-Medical Division

Risk Factors
Genetic Age ( with age) Sex (> female)

Obesity
Joint trauma and injury
Repetitive occupational joint use Physical inactivity

Sciops-Medical Division

RA - Pathology & Pathogenesis


Active chronic inflammation of the synovial membrane

Synovial membrane proliferation and out-growth

Erosion of the articular cartilage and sub-chondral bone

Formation of the characteristic pannus

First affects the small joints Order of involvement : fingers, toes, hands, knees, elbows, shoulders and hips. Sciops-Medical Division

Signs and symptoms of RA


Signs
Hand joint deformities such as Boutonnire and Swan neck & subcutaneous nodules Synovium hypertrophy Bone erosion Rheumatoid factor present in 85% of patients

Symptoms
Joint swelling, warmth and tenderness

Pain and stiffness


Weakness, fatigue Fever Depression

Hope R, et al. 1998

RA - Hand Involvement

Sciops-Medical Division

Subcutaneous NodulesOver Elbow in Rheumatoid Arthritis Severely Affected Hand With Subcutaneous Nodules Over Knuckle, Swan Neck Deformity Of Middle Finger, Wasting Of Hand, and Ulnar Drift of Fingers

Sciops-Medical Division

RA - Laboratory Findings
The erythrocyte sedimentation rate (ESR) is elevated in most patients.

The presence of RF (85%)


Antinuclear antibodies (30-40%)

Sciops-Medical Division

RA Management Goal

1.
2. 3. 4.

Relief of pain
Reduction of inflammation Preservation of muscle strength and joint function Return as rapidly as possible to a normal lifestyle

Sciops-Medical Division

Management
Pain relief with NSAIDs Adequate rest Weight reduction Immunosuppressive Local corticosteroid injections Long term corticosteroids (should be preserved for pts with aggressive joint
reaction whose ability to function is threatened)

Prolonged home exercise program

Sciops-Medical Division

Differential diagnosis of OA from RA


OA
Patient typically >45 years at onset Asymmetrical joints Joint space narrowing More common in hip and knee Joint tenderness
Sciops-Medical Division

RA
Patient typically 2555 years at onset More common in wrist, elbow and shoulder

Usually symmetrical joint involvement


Joint warmth and redness

Sciops-Medical Division

Ankylosing Spondyltis

Classic areas of inflammation in ankylosing spondylitis

Sciops-Medical Division

Ankylosing Spondylitis
Ankylosing spondylitis (AS) is a chronic inflammatory disease of the axial skeleton manifested by back pain and progressive stiffness of the spine. AS is one of the spondyloarthropathies which show inflammation around the enthesis (the site of ligament insertion into bone) and an association with the human leukocyte antigen HLA-B27. It characteristically affects young adults with a peak age of onset between 20 and 40 years. Although classically thought of as a spinal disease, transient acute arthritis of peripheral joints (hips, shoulders, knees) occurs in up to 50 percent of patients

Sciops-Medical Division

Ankylosing spondylitis
There are three clinical criteria: Low back pain Morning stiffness of greater than three months duration, improving with exercise but not relieved by rest

Limitation of motion of the lumbar spine


It can result in the following
Fused vertebrae

Rigid spine, and


Flattening of the lower back. The joints and ligament become inflamed.
Sciops-Medical Division

Ankylosing Spondylitis {AS}


Investigations:
X-ray findings (bilateral sacrolitis; bamboo spine..) ESR

HLA-B27 (95% of cases) (human leukocytic antigen) not all


RF -ve

Treatment:
Active mobilisation and spine exercises are very important. NSAIDs

Sciops-Medical Division

Non Articular Rheumatism Soft Tissue Rheumatism

Non Articular Rheumatic disorders


Most common Rheumatic disorders where joints arent
affected .

Referred to muscular , adipose tissue , tendons , joint


capsules and bursa.

Both inflammatory & Degenerative processes play role.

Most prominent symptoms are pain and tenderness.


Sciops-Medical Division

Non Articular Rheumatic disorders


Disorder
Bursitis

Pathology
Pleural of bursa is synovial sacs that lies between tendons ,bones and muscles or tendons and skin Function is to minimize friction Inflammation of bursa is associated with swelling , redness of skin and limitation of movement of nearby joints Changes affecting tendons and their sheath due to micro trauma or occupational origin Inflammation in synovial membrane Inflammation in the tissues surrounding the joints , the bursae is often involved Pain , tenderness , due to acute or chronic inflammation of muscles

Tendonitis / Tenosynovitis Synovitis Periarthritis

Myositis
Sciops-Medical Division

Management of Non Articular Rheumatic disorders


Rest NSAIDS

Local steroids
Physiotherapy

Sciops-Medical Division

Thank you

You might also like